Editor's Note: Green and red arrows refer to intraday stock price movement.NEW YORK ( TheStreet) -- CHANGE IN RATINGS Adobe Systems ( ADBE) upgraded at UBS from Neutral to Buy, UBS said. $40 price target. Survey suggests that demand is stabilizing. Citigroup ( C) downgraded at Goldman to Buy from Neutral, Goldman Sachs said. Company also removed from the Conviction List. Cheesecake Factory ( CAKE) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $36 price target. Valuation call, following the recent pullback. CBOE Holdings ( CBOE) upgraded at Credit Suisse to Outperform from Neutral. Strong fundamentals and more deals coming, Credit Suisse said. Price target raised to $32 from $25. Copart ( CPRT) rated new Buy at Goldman. $48 price target. Company can deliver consistent cash flow growth. Coinstar ( CSTR) downgraded at JP Morgan from Neutral to Underweight. $42 price target. Consensus estimates appear too high. Fifth Third ( FITB) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $17 price target. Company has the most relative excess capital. First Solar ( FSLR) estimates, target boosted at Goldman. Shares of FSLR now seen reaching $190, according to Goldman Sachs. Estimates also upped, given improved volume visibility. Buy rating. First Solar ( FSLR) downgraded at UBS from Buy to Neutral, UBS said. Valuation call, based on a $180 price target. Foster Wheeler ( FWLT) downgraded at BB&T to Hold, BB&T Capital said. Company guided toward lower near-term margins. Goldcorp ( GG) upgraded at Deutsche to Buy, Deutsche Bank said. Company is seeing solid growth an boosted its dividend. $60 price target. Hill-Rom ( HRC) upgraded at Soleil from Accumulate to Buy, Soleil Securities said. Valuation call, based on a $54 price target. Hospital spending appears to be improving. InterActiveCorp ( IACI) rated new Hold at Canaccord. $28 price target. Stock is pricing in the potential for increased competition. LDK Solar ( LDK) rated new Buy at Kaufman. $24 price target. Stock trades at a significant discount to its peers. MedAssets ( MDAS) downgraded at Deutsche to Hold. $19 price target. Company has limited earnings visibility. MedAssets downgraded at Piper to Underweight. $15 price target. Company is seeing lower growth across the board. MedAssets downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. $18 price target. Company slashed its forward guidance. MedAssets downgraded at Citi from Buy to Hold on disappointing 4Q10 results, Citigroup said. Price target cut to $20 from $26. MedAssets downgraded at Baird from Outperform to Neutral. $18 price target. Company lowered its earnings outlook.